Regulatory Compliance for Fluorosilicone Release Liners – Global Standards and Requirements
Discover the global compliance requirements for fluorosilicone release liners, including RoHS, REACH, PFAS, and DMF Type III, with guidance for both industrial and medical applications.
Last updated:
1. Why Compliance Matters More Than Ever
Release liners are often seen as invisible packaging layers. In reality, they are increasingly under scrutiny as global regulators tighten chemical safety and packaging compliance rules. For fluorosilicone release liners, compliance is no longer optional—it determines whether materials clear customs, pass audits, and stay qualified in supply chains.
- Industrial applications: Customers in electronics, automotive, and adhesive tapes routinely request RoHS, REACH, PFAS, and SDS as baseline documents.
- Medical applications: For transdermal patches and wound dressings, an active DMF Type III (Drug Master File for packaging) is often a prerequisite for FDA filings.
- Risks of missing documents Gaps can trigger customs delays, failed audits, or disqualification from approved supplier lists.
2. Key Global Regulations
EU – Continuous obligations rather than one-time approvals
-
REACH (EC 1907/2006) – Requires notification of SVHCs (Substances of Very High Concern) and compliance with Annex XVII restrictions. The SVHC list is updated every six months, meaning outdated reports quickly lose validity.
-
RoHS (2011/65/EU) – Restricts 10 substances (heavy metals and phthalates) with ppm thresholds; XRF and ICP-OES are common verification methods.
-
PFAS restriction proposal – ECHA’s 2023 draft, updated in 2025, now covers 18 application areas. Final adoption is expected within the next few years.
US – Federal plus state-level complexity
-
EPA PFAS Reporting Rule (40 CFR Part 705, 2023) – Mandatory PFAS reporting for manufacturers and importers.
-
OSHA HAZCOM (29 CFR 1910.1200) – Requires SDS (Safety Data Sheets) in GHS format, replacing the outdated MSDS.
-
State-level bans – Maine, California, and New York already restrict PFAS in packaging; additional states are preparing similar laws.
-
DMF Type III – For pharmaceutical packaging, suppliers must maintain an active file with the FDA and issue Letters of Authorization (LOAs) for clients’ submissions.
Asia-Pacific (APAC)
-
China – China RoHS 2.0, China REACH (MEE Order No. 12, 2021).
-
Korea – K-REACH and Korea RoHS, both aligned with EU frameworks but locally enforced.
-
Japan – CSCL (Chemical Substances Control Law).
3. Compliance Priorities for Fluorosilicone Release Liners
Buyers distinguish between must-have documents and those that strengthen supplier credibility.
Category | Documents | Applicability |
|---|---|---|
Mandatory |
| Required for both industrial and medical markets |
Medical Core | DMF Type III (with LOA) | U.S. market – pharmaceutical patches, wound dressings |
Buyer-Driven |
| Common in audits by global pharma and electronics firms |
4. Common Declarations in the Medical Sector
While not legally mandated, these declarations are frequently requested during audits:
BSE/TSE Free Statement – Confirms no materials of animal origin.
Residual Solvent Declaration (ICH Q3C) – Ensures solvent levels are within safe limits.
Elemental Impurities Statement (ICH Q3D) – Addresses heavy metal risks.
Latex-Free and Allergen-Free Statements – Eliminates risks of allergic reactions.
Nitrosamine-Free Statement – Increasingly requested due to pharma safety concerns.
These are usually delivered as signed declarations rather than full laboratory reports.
5. Testing and Renewal
- RoHS → Screening via XRF, confirmed with ICP-OES or AAS.
- REACH → Based on the SVHC list, updated twice per year.
- PFAS → Tested with LC-MS/MS or TOP assay, covering hundreds of compounds.
- SDS → Must meet GHS format, with 16 required sections.
- DMF Type III → Must stay active in FDA records, with LOAs issued when needed.
Reports must be renewed to align with the latest lists and standards. Outdated versions risk rejection.
6. Building a Compliance Package – What You Receive
Working with us means fewer surprises in audits and submissions.
-
Baseline documents – RoHS, REACH, SDS, and PFAS statements aligned with the latest lists.
-
Medical extensions – Active DMF Type III filings with FDA and LOAs ready for reference in ANDA/NDA submissions.
-
Audit supplements – ISO 13485, ISO 9001/14001, ESG questionnaires, and LCA reports, depending on buyer requirements.
-
Delivery format – Standardized templates, bilingual (EN/CN) options, validity dates clearly marked for audit readiness.
7. Case Studies (Anonymous)
- Industrial – PFAS Documentation Missing An electronics supplier failed to provide updated PFAS compliance reports under EU REACH. Their goods were held at EU customs, and the client replaced them with a supplier that could deliver REACH SVHC declarations and PFAS test reports on time.
- Medical – No DMF Type III in FDA Records A packaging supplier without an active DMF Type III blocked their pharma client’s ANDA submission. The missing Letter of Authorization (LOA) caused a six-month delay in the drug launch and additional stability testing costs.
- Cross-Region – Conflicting RoHS Reports A supplier submitted inconsistent RoHS compliance reports for EU (2011/65/EU) and China RoHS 2.0. The discrepancy triggered a customer audit, forced retesting of production batches, and delayed shipments.
8. FAQ
RoHS restricts a fixed list of hazardous substances at ppm thresholds, typically reviewed in electronics and automotive audits. REACH requires continuous monitoring of the SVHC list, updated every six months, and is mandatory for industrial exports to the EU. Many buyers require both, since RoHS alone does not cover broader REACH obligations.
Yes, but only for pharmaceutical uses such as transdermal patches and wound dressings. For these, suppliers must maintain an active DMF Type III and issue LOAs for FDA submissions. Industrial markets do not require DMFs.
Even when not requested, PFAS reports are increasingly critical as EU proposals and U.S. state laws tighten. Proactively providing LC-MS/MS reports or PFAS-free statements reduces the risk of customs delays or buyer rejections.
Compliance reports should align with the latest lists and standards. REACH SVHC lists update every six months; many buyers impose 12-month validity on RoHS and PFAS tests. ISO certifications usually expire annually or every three years. Best practice: update before audits to avoid disputes.
MSDS is an outdated format with inconsistent structures. SDS follows the GHS 16-section standard and is the only document accepted by regulators and buyers today. Release liner suppliers must always provide SDS to meet global chemical safety documentation requirements.